Quick Summary:
Dive into the robust world of the Artificial Pancreas Device Systems Industry. The global artificial pancreas device systems market - valued at US$345.1 million in 2022 - is a rapidly growing sector, braced to reach a staggering US$1.4 billion by the year 2030. This growth is powered by advancements in medical technology and the expanding needs of diabetics for effective and cutting-edge medical solutions.
Our comprehensive market research report is an indispensable tool for business executives looking to gain a competitive edge. It offers in-depth analyses and accurate projections, tracking the performance of key geographic markets including the US, China, Japan, Canada, and Germany. Furthermore, the report has a razor-sharp focus on the trajectories of top competitors such as Beta Bionics, Inc., Bigfoot Biomedical, Inc., Johnson & Johnson, Medtronic PLC, Pancreum, Inc., Tandem Diabetes Care, Inc., and TypeZero Technologies LLC. Additionally, gain critical insights into new developments on the horizon with our special features. Equip your business with the data needed to strategize and stay ahead in this dynamic industry.
Global Artificial Pancreas Device Systems Market to Reach $1.4 Billion by 2030
The global market for Artificial Pancreas Device Systems estimated at US$345.1 Million in the year 2022, is projected to reach a revised size of US$1.4 Billion by 2030, growing at a CAGR of 18.7% over the analysis period 2022-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is projected to record 18.8% CAGR and reach US$1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Control-to-Target (CTT) Systems segment is readjusted to a revised 19.6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $105 Million, While China is Forecast to Grow at 17.9% CAGR
The Artificial Pancreas Device Systems market in the U.S. is estimated at US$105 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$230.2 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.5% and 15.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.6% CAGR.Select Competitors (Total 47 Featured) -
- Beta Bionics, Inc.
- Bigfoot Biomedical, Inc.
- Johnson & Johnson
- Medtronic PLC
- Pancreum, Inc.
- Tandem Diabetes Care, Inc.
- TypeZero Technologies LLC
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Artificial Pancreas Device Systems?
What is the growth rate of the Global Market for Artificial Pancreas Device Systems?
What is the forecasted size of the Global Market for Artificial Pancreas Device Systems?
Who are the key companies in the Global Market for Artificial Pancreas Device Systems?
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 345.1 Million |
| Forecasted Market Value ( USD | $ 1400 Million |
| Compound Annual Growth Rate | 19.1% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Beta Bionics, Inc.
- Bigfoot Biomedical, Inc.
- Johnson & Johnson
- Medtronic PLC
- Pancreum, Inc.
- Tandem Diabetes Care, Inc.
- TypeZero Technologies LLC
